Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Researchers from the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena, Germany, the Molecular Biotechnology ...

The human gut renews itself faster than any other tissue: every few days, new cells are created from specialized stem cells.

Researchers from the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena, Germany, the Molecular Biotechnology ...

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells. While islet ...

Interested parties may access the audio webcast for the conferences via the Investors section of the Surrozen website at https://investors.surrozen.com/events-presentations/events-calendar. A replay ...

The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological ...

A lightning-fast imaging method is exposing the hidden mechanics of brain-cell communication and offering new clues to Parkinson’s origins.

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by differences in communication, behavior and ...

Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer, today announced preliminary clinical data demonstrating the ...

Heidelberg University has been successful in the current approval round of the German Research Foundation (DFG) with three grant applications for major research consortia. For the three Collaborative ...

An investigator-developed drug has shown preclinical efficacy and is worth testing in clinical trials in aggressive breast ...